ARUP's Laboratory Test Directory

0051176: Galactosemia, GALT Gene Mutations

[ image for: Patient History For Galactosemia]
Patient History For Galactosemia
  

Test Mnemonic: GALTDNA
Methodology: Polymerase Chain Reaction/Single Nucleotide Extensions

Performed: Tue, Thu

Reported: 10-14 days

Specimen Required:  
Collect: One 3 mL lavender (EDTA), pink (K2EDTA) or yellow (ACD solution A or B).

Transport: 3 mL whole blood at 2-8°C. (Min: 1 mL)

Pediatric Collection/Transport: 1 mL whole blood at 2-8°C.

Stability: Ambient: 3 days; Refrigerated: 1 week; Frozen: Unacceptable

Reference Interval:
By report

Interpretive Data:
Background Information:
Characteristics
: Affected infants present at 3-14 days old with poor feeding, vomiting, diarrhea, jaundice, lethargy progressing to coma, and abdominal distension with hepatomegaly usually followed by progressive liver failure. Patients with galactosemia are also at increased risk for E. coli or other Gramnegative neonatal sepsis. Diagnosis is made by measuring GALT enzyme activity in red blood cells.
Incidence:
Approximately 1:120 in Caucasians; less common in other ethnic groups.
Inheritance
: Autosomal recessive
Penetrance
: 100% for severe GALT mutations.
Cause:
Mutations in the GALT gene.
Mutations Detected:
Seven GALT gene mutations (Q188R, S135L, K285N, T138M, L195P, Y209C, and IVS2-2 A>G) and two variants (N314D and L218L).
Clinical Sensitivity
: Approaches 80% in Caucasians but reduced in other ethnic groups.
Methodology
: Polymerase chain reaction followed by single nucleotide extension (SNE) and capillary electrophoresis.
Analytical Sensitivity:
99% for mutations listed.
Limitations:
Other mutations will not be detected.

This test is performed pursuant to an agreement with Roche Molecular Systems, Inc.



Counseling and informed consent are recommended for genetic testing. Consent forms are available online at www.aruplab.com.

Please refer to Statement C in the Compliance Statements section in the front of the Laboratory Test Directory.



Note:
This test is offered to individuals with known familial mutation(s).

CPT Code(s):
83890 Isolation; 83898 Amplification; 83914 x9 Mutation identification; 83909 Capillary electrophoresis; 83912 Interpretation and report - Additional CPT code modifiers may be required for procedures performed to test for oncologic or inherited disorders.

 

 

 
All ARUP Sites:        www.aruplab.com     ·     www.arupconsult.com     ·     www.arup.utah.edu     ·     www.childx.org     ·     www.utahblood.org